An observational study in Severe Mental Disorder, Schizophrenia and Personality Disorders, sponsored by Sheba Medical Center. Recruiting at 1 site in Israel. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-25.
Sponsored by Sheba Medical Center · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study presents the development and validation of a unique Digital Experience Sampling Method (ESM) questionnaire specifically adapted for monitoring changes in the mental state of patients during psychiatric hospitalization. The questionnaire was carefully crafted through focus groups involving patients and clinical staff, ensuring its relevance and applicability to the unique characteristics of mental state changes in a hospitalization setting.
To evaluate the validity of the ESM questionnaire, symptom severity trends obtained from the questionnaire will be compared with estimates derived from the Positive and Negative Syndrome Scale (PANSS) assessment. Data will be collected from 100 subjects over a 14-day psychiatric hospitalization period. In addition to the ESM questionnaire, smartwatch sensors will monitor physiological indicators.
Feasibility and patient compliance will be assessed by examining patients' willingness to use the digital ESM questionnaires and the smartwatch sensors. The study will also cross-reference self-reported sleep quality and activity levels captured in the ESM questionnaires with objective physiological indicators and nursing staff reports, providing insights into the reliability of the patient-reported data.
Furthermore, the study will evaluate the impact of the ESM data on clinical decision-making by physicians throughout the 14-day psychiatric hospitalization period. Patient satisfaction and satisfaction among the multidisciplinary team with the monitoring model will also be assessed.
This research underscores the potential of digital technologies to enhance patient-centered care and facilitate informed treatment decisions in psychiatric hospitalization settings.
The research will be carried out in two phases:
Focus group No. 1: The first focus group included patients hospitalized in the psychiatric ward. The purpose of the focus group is to formulate the ESM core and additional content domains and the questionnaire items and to discuss the optimal measurement frequency according to the hospitalized patients' opinions. The focus group will also examine the wording that best suits how the patients describe their mental state.
Indices The subjects' point of view regarding the psychiatric symptoms they suffered from during their hospitalization was examined during a free discussion. Emphasis was placed on the symptoms that change daily throughout the hospitalization and how much they indicate a change in their mental state. The investigators also investigated what information they would like to report to the treatment team about their mental state throughout the hospitalization. After the free discussion, the position of the subjects was examined regarding the criteria for assessing mental state as they emerged from the monitoring scales of the PROM questionnaires.
After a qualitative analysis of the information collected at this stage, the main themes of the ESM questionnaire were formulated. According to the themes found, suggestions were developed for the questionnaire items while noting how the patient's symptoms were worded. A professional transcriber transcribed the discussion.
Focus group No. 2: The second focus group includes a multi-disciplinary team working in the psychiatric inpatient wards. In a free discussion, the multi-disciplinary team members examined the core issues that should appear in the questionnaire for monitoring the mental state of hospitalized patients, then explored and expressed their opinion regarding the issues raised by the patients in the first focus group. The result of this step will be an ESM questionnaire adapted to the needs of the patients and the clinical staff in the inpatient wards.
Indices In the discussion, the participants floated important themes for monitoring according to their points of view. After a free discussion, the participants were presented with the themes raised by the patients in the previous focus group. They were also presented with the possible questionnaire items formulated after the last stage, and their position was examined regarding the appropriateness of fitting these items to the questionnaire. In addition, the discussion dealt with the optimal sampling frequency, in their opinion.
The initial formulation of the ESM questionnaire items. The questionnaire items were formulated considering the information collected in the focus groups. An effort was made to use the patients' words to ask about their mental state. In addition, existing and valid self-report items marked as necessary by the patients and staff in the focus groups discussion were selected. Items from these questionnaires were reformulated according to the ESM approach that examines the current state. At the end of this stage, an ESM questionnaire was developed, which consists of 15 items on a five levels Likert scale. In the questionnaire, there was another item of a Visual Analogue Scale type where the subject had to mark his mood on a scale ranging from 1-100.
Indices For each item in the developed ESM questionnaire, subjects were asked to describe freely what they thought the item was testing. In addition, to each item, the investigators discussed how appropriate the question was in their opinion to describe their mental state throughout the hospitalization and whether they would change anything in the wording. At the end of this part of the discussion, the subjects were asked how many times a day they would be willing to report their mental state, how many items they would be ready to answer, and what additional questions they would like to be asked to learn about their condition. In addition, the investigators examined the patients' attitudes regarding their agreement to answer questions via mobile phone and their agreement to continue answering a similar questionnaire after their discharge from the hospital.
Research Process The focus groups were held at Sheba Medical Center on 5/18/22, 08/9/22, and 11/09/22. The groups were guided by the researcher and another facilitator, who work as senior clinical psychologists in the psychiatric inpatient wards at the Sheba Medical Center. A professional transcriber attended each group and typed the conversation throughout the focus groups. The transcripts of the discussions in the focus groups were qualitatively analyzed. After collecting and processing the data from the focus group, the ESM questionnaire was improved and refined, considering the findings.
Participants
To conduct the monitoring model, the investigators will recruit 100 subjects hospitalized in the inpatient wards. To receive feedback on implementing the monitoring model from the multi-disciplinary care team working in the wards, the investigators will recruit 30 multi-disciplinary team members. The running will be carried out in two stages:
Pre-Test - 20 patients and feedback from 5 multi-disciplinary - estimated time - 3 months.
Field Test - 80 additional patients and feedback from 30 multi-disciplinary staff members - estimated 12 months.
Indices Pre-test indices -
Feasibility and compliance:
The validity of the subject's self-reports on sleep quality and activity level:
The validity of the subject's self-reports on his activity level:
The subject's self-reported data about his energy and activity level will be compared to physiological indicators that the smartwatch will collect (number of steps, accelerations) and will be equalized in addition to the reports of the nursing staff in the ward.
Research Process After recruiting the patient for the study and signing informed consent, the monitoring application (Datos Health) and the wearable smartwatch application (Garmin) will be installed on the patient's smartphone. The patient will receive an extensive explanation from the research team's representative on the self-reporting method and will experience using the application.
From this stage, the hospitalized subject will receive ongoing clinical care, alongside participation in monitoring indicators by self-reporting in the ESM questionnaires using the Datos Health application and physiological indices monitoring by using the Garmin smartwatch. The trial will end after 14 days or until the patient's discharge (whichever comes first). The ESM self-report sampling will be conducted a frequency of 3 times a day in a semi-random manner:
The feasibility and compliance, Validity, and changes in the patient's condition over timeline indicators will be collected for 14 days and analyzed at the study's end. The patient satisfaction indicators will be tested after 14 days of monitoring through a questionnaire sent to each subject. The satisfaction indicators of the clinical staff in the ward will be tested through questionnaires sent to the clinical staff at the end of the study.
1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.
This study's planned enrollment of 130 is below the median of 220 across 391 observational studies indexed under Mental Disorders.
Browse Mental Disorders studies →Sheba Medical Center is the lead sponsor of 680 studies on the registry; 65 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Focus group No. 1: The first focus group included patients hospitalized in the psychiatric ward. Recruited nine subjects over age 18 (6 women and three men).
Focus group No. 2: The second focus group includes a multi-disciplinary team working in the psychiatric inpatient wards. Recruited seven staff members working in the psychiatric hospitalization wards in Sheba Medical Center (3 women and four men), participated in the focus group.
Focus group No.3: The third focus group included hospitalized inpatients for cognitive debriefing. Recruited six subjects over 18 (two women and four men).
To conduct the monitoring model, we will recruit 100 subjects hospitalized in the inpatient wards. To receive feedback on implementing the monitoring model from the multi-disciplinary care team working in the wards, we will recruit 30 multi-disciplinary team members.
Focus group no.1 :
Inclustion Criteria-
Focus group no.2:
Inclusion Criteria:
No Exclusion Criteria.
Focus group no.3-
Inclustion Criteria:
Exclusion Criteria:
Monitoring model- The investigators will recruit 100 subjects hospitalized in the inpatient wards.
Inclusion criteria:
Exclusion criteria:
The study inclusion criteria for the multi-disciplinary team:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The primary objective of this study is to validate the ESM questionnaire by comparing the trends in symptom severity as reported through the ESM questionnaire with the PANSS assessment of symptom severity.
The positive and negative syndrome scale (PANSS) for schizophrenia is measuring the severity of symptoms in patients with schizophrenia spectrum disorders. It is conducted through a brief interview rather than a self-report. The ESM (Experience Sampling Method) is a method Structured based on a diary, in which the subjects are asked to report their thoughts, feelings, and symptoms during their daily life, as well as to describe the context in which the report takes place. The validation of the ESM questionnaire will be conducted by comparing the change trends in the questionnaire indices during a 14-day psychiatric hospitalization period to the change trends in four different measurements of psychiatric symptoms assessed by the PANSS diagnostic tool, which is widely recognized as the gold standard in psychiatric symptom assessment. The subject's assessment using PANSS will be conducted at three different time points.
Time frame: 14 days.
Development of the monitoring questionnaire - Content validity phase.
The subjects' point of view regarding the psychiatric symptoms they suffered from during their hospitalization was examined during a free discussion. Emphasis was placed on the symptoms that change daily throughout the hospitalization and how much they indicate a change in their mental state. We also investigated what information they would like to report to the treatment team about their mental state throughout the hospitalization. After the free discussion, the position of the subjects was examined regarding the criteria for assessing mental state as they emerged from the monitoring scales of the PROM questionnaires. After a qualitative analysis of the information collected at this stage, the main themes of the ESM questionnaire were formulated. According to the themes found, suggestions were developed for the questionnaire items while noting how the patient's symptoms were worded. A professional transcriber transcribed the discussion.
Time frame: 14 days
Investigation of the feasibility and compliance of patients in responding to self-report questionnaires.
The responsiveness to participation in the monitoring model - The extent of responding to the self-report questionnaires over 14 days multiplied by three times a day.
Time frame: 14 days
Investigation of the feasibility of patients in participating in the study.
The responsiveness to participation in the study - The number of subjects who agreed to participate in the study out of the subjects we offered to participate.
Time frame: 14 days
Investigation of the feasibility and compliance of patients with different diagnoses in participating in the study.
The responsiveness to participation in the monitoring model - The number of subjects who agreed to participate in the study out of the subjects we offered to participate. The degree of difference between subjects with different psychiatric diagnoses (psychotic spectrum, depression, mania, and personality disorders) in their adherence and responsiveness to agree to participate in the study, answer the self-report ESM questionnaires and wear and charge the smartwatch.
Time frame: 14 days
The validity of subjects' self-reports on sleep quality and activity level will be assessed by comparing the self-report ESM data with the physiological indicators collected by the smartwatch.
The ESM indices will be compared to reports from the nursing staff on the ward. Furthermore, we will explore whether these comparisons yield different outcomes among subjects with different psychiatric diagnoses.
Time frame: 14 days
Testing the effectiveness of the monitoring model.
The effectiveness will be assessed by examining the impact of exposing the psychiatrists to ESM data, as well as the physiological indicators collected by the smartwatch, on the decision-making process regarding changes in the patient's medication plan during psychiatric hospitalization.
Time frame: 14 days
Assessing patient satisfaction with the monitoring model used throughout their 14-day hospitalization.
Following the monitoring period, subjects will be asked to provide feedback on their satisfaction levels through questionnaires.
Time frame: 14 days
Assessing the satisfaction of the multi-disciplinary teams.
At the end of the study, the teams will report through questionnaires on their satisfaction with using this monitoring model and its influence on the team's clinical decision-making.
Time frame: 14 days
Investigation of the feasibility and compliance of patients to instructions of smartwatch use.
The degree of responsiveness to instructions regarding the use of the smartwatch for 14 days.
Time frame: 14 days
Plan to share: Undecided
Started May 2022 (actual). Primary completion is estimated for Oct 2024, 29 months after the start.
Of 150 non-industry observational studies under Mental Disorders, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 77. This study's planned 29 months is below that.
Counting every sponsor, half of 157 studies reached it within 37 months; a quarter within 13 and three quarters within 77.
Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.